| Darlene Flint, CRNA | |
|
2855 Campus Dr, Plymouth, MN 55441-2649 | |
| (763) 577-7000 | |
| (763) 577-7130 |
| Full Name | Darlene Flint |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 2855 Campus Dr, Plymouth, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093734311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R064340-9 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darlene Flint, CRNA 10522 Briar Rd, Bloomington, MN 55437-2745 Ph: (952) 948-1664 | Darlene Flint, CRNA 2855 Campus Dr, Plymouth, MN 55441-2649 Ph: (763) 577-7000 |
News Archive
The Commonwealth Government will provide free vaccines to protect newborn babies and older people from pneumococcal disease, as well as a catch up program for toddlers.
Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints-a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding-as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
QPID Inc. launched today, delivering a new health record intelligence platform and web-based applications that enable health care institutions and clinicians to gain better insights from any Electronic Health Record (EHR).
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, a cancer research cooperative group funded by the National Cancer Institute (NCI).
Celgene International Sà rl (NASDAQ: CELG) announced that data evaluating combination therapy REVLIMID® (lenalidomide) and dexamethasone in patients with high-risk asymptomatic smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting. The study reported REVLIMID and dexamethasone prolonged time to progression.
› Verified 6 days ago
Nickolas C Southwick, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 14700 28th Ave N Ste 20, Plymouth, MN 55447 Phone: 763-559-3779 Fax: 763-450-3986 | |
Jayne Eberhardt, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2855 Campus Dr, Plymouth, MN 55441 Phone: 763-577-7000 | |
Anna Spillers, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 14700 28th Ave N Ste 20, Plymouth, MN 55447 Phone: 763-559-3779 Fax: 763-450-3986 | |
Peter Lawrence Sedlacek, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Plymouth, MN 55441 Phone: 763-577-7000 Fax: 763-577-7130 | |
Dillon Joseph Dryja, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 14700 28th Ave N Ste 20, Plymouth, MN 55447 Phone: 763-852-0411 | |
Theresa M Geoffrion, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 14700 28th Ave N Ste 20, Plymouth, MN 55447 Phone: 763-559-3779 | |
Mowoh A Endeley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 14700 28th Ave N Ste 20, Plymouth, MN 55447 Phone: 763-559-3779 Fax: 763-450-3986 |